How VYVGART helped reduce my gMG symptoms

Marge was diagnosed with anti-AChR antibody positive generalized myasthenia gravis (gMG) in 2018 and started on VYVGART for intravenous (IV) infusion in 2022. In this guest post, she shares how VYVGART helped reduce multiple symptoms she’d experienced over the years and why a lifelong attitude of hope has been important to her journey.

Marge
Started on VYVGART for IV infusion in 2022

Marge is a paid spokesperson of argenx.

My father had the worst luck, but the best attitude. He told me, “If all you see on a bad day is a flower, it was a good day.” And I’ve always held on to that sentiment.

My parents came from a farming and fishing community in Cape Breton, an island off the coast of Nova Scotia. We weren’t wealthy, but we were happy and had what we needed. My father’s hopeful outlook helped shape an ideal 1950s childhood of dancing, reading, and even developing trade skills like carpentry. And that hope has stayed with me throughout my life, especially during my gMG diagnosis.

It's difficult to pinpoint exactly when my gMG symptoms started. Looking back at photos from grade school, I noticed my eyes didn’t open wide. But I didn’t think anything of it at the time. I also remember feeling generally tired but just thinking it was due to my active lifestyle. Now I wonder if some of that was because of gMG: Were my droopy eyelids a gMG symptom? Was my muscle fatigue a gMG symptom?

In these educational guides, learn more about the gMG symptoms that may affect you.

The first experience that really alarmed me was in 2018 when I was preparing a litter of puppies to go to their “forever homes.” As much as I loved caring for them, it was very tiring. I wanted to take naps and when I wasn’t able to, my speech would start slurring. To make matters worse, I was scared to eat because I was also having a hard time swallowing. A nurse who picked up one of the puppies thought I was having a stroke and recommended I go to the ER. After days at the hospital with doctors evaluating my condition, I asked to see a speech specialist since my symptoms were mainly around my throat. Once that specialist spoke with the doctors, my anti-AChR antibody positive gMG diagnosis was confirmed.


“During my first treatment cycle, the nurse said she could see a difference, and so could I.”


While I was on my initial treatments for gMG, my doctor told me about VYVGART for IV infusion. I wanted to take it as soon as I could. Before I was prescribed, my doctor told me that the most common side effects are respiratory tract infection, headache, and urinary tract infection. During my first treatment cycle, the nurse said she could see a difference, and so could I. My eyes could finally open up wider. Then, I noticed an improvement in my ability to walk and use my arms. But the biggest triumph was I could comfortably eat a meal!

Working with my doctor has helped determine a treatment plan based on my symptoms. I get 1 treatment a week for 4 weeks, with a break between cycles that works for me. I track my symptoms with the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale every week to help recognize my results, particularly in symptoms related to my throat and muscles. It also helps me share progress with my healthcare team and it really makes me think: Are things going steadily? Have my symptoms gotten worse or better? It's a particularly great tool to share with my doctor. My experience with VYVGART has generally been wonderful, and I see that in my MG-ADL scores.

Use the MG-ADL scale to help track your symptoms.

Today, gMG is something I have to keep in mind, but I can fill my days with some activities I enjoy, like cooking meals from scratch, taking Tai Chi classes, and spending time with my dogs.

Doug Doug Doug
Doug Doug Doug

For me, VYVGART has renewed my hope and helps manage some of my symptoms that I experience in my everyday life. I encourage others in the gMG community to talk to their doctor about how to manage their unique symptoms in a way that works for them. Everyone has different experiences and deserves to be heard. I wish for others in the gMG community to hold on to my father’s message of hope, so they, too, can find the flowers in the bad days.

AChR=acetylcholine receptor; ER=emergency room; gMG=generalized myasthenia gravis; IV=intravenous; MG-ADL=Myasthenia Gravis Activities of Daily Living


VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) Subcutaneous Injection 180 mg/mL and 2000 U/mL vial; VYVGART (efgartigimod alfa-fcab) Injection for Intravenous Use 400 mg/20 mL vial
VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) Subcutaneous Injection 180 mg/mL and 2000 U/mL vial; VYVGART (efgartigimod alfa-fcab) Injection for Intravenous Use 400 mg/20 mL vial

Still have questions? Call 1-833-VYVGART (1-833-898-4278) to speak with an educator about gMG, how VYVGART works, study data, cost and coverage, and more.

Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART and VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART and VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART or VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART or VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.

Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART and VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART and VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART or VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART or VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.